429 related articles for article (PubMed ID: 19356514)
1. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake.
Michaels AD; Klein A; Madden JA; Chatterjee K
Circulation; 2003 Jun; 107(21):2697-701. PubMed ID: 12742984
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
Michaels AD; Chatterjee K; De Marco T
J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
[TBL] [Abstract][Full Text] [Related]
4. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
[TBL] [Abstract][Full Text] [Related]
5. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.
Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K
J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005
[TBL] [Abstract][Full Text] [Related]
6. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
7. Nesiritide: a review of its use in acute decompensated heart failure.
Keating GM; Goa KL
Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
[TBL] [Abstract][Full Text] [Related]
8. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.
Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP
Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311
[TBL] [Abstract][Full Text] [Related]
9. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
[TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic effects of intravenous nesiritide on left ventricular diastolic function in heart failure patients.
Efstratiadis S; Michaels AD
J Card Fail; 2009 Oct; 15(8):673-80. PubMed ID: 19786256
[TBL] [Abstract][Full Text] [Related]
11. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
Abraham WT; Cheng ML; Smoluk G;
Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of intravenous nesiritide on cardiac contractility in heart failure.
Shah SJ; Michaels AD
J Card Fail; 2010 Sep; 16(9):720-7. PubMed ID: 20797595
[TBL] [Abstract][Full Text] [Related]
13. Nesiritide for the treatment of decompensated heart failure.
Colucci WS
J Card Fail; 2001 Mar; 7(1):92-100. PubMed ID: 11264555
[TBL] [Abstract][Full Text] [Related]
14. Nesiritide acutely increases pulmonary and systemic levels of nitric oxide in patients with pulmonary hypertension.
Khush KK; De Marco T; Vakharia KT; Harmon C; Fineman JR; Chatterjee K; Michaels AD
J Card Fail; 2006 Sep; 12(7):507-13. PubMed ID: 16952783
[TBL] [Abstract][Full Text] [Related]
15. Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure.
Elkayam U; Cohen G; Gogia H; Mehra A; Johnson JV; Chandraratna PA
J Am Coll Cardiol; 1996 Jul; 28(1):176-82. PubMed ID: 8752811
[TBL] [Abstract][Full Text] [Related]
16. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure.
Elkayam U; Weber L; Campese VM; Massry SG; Rahimtoola SH
J Am Coll Cardiol; 1984 Dec; 4(6):1261-7. PubMed ID: 6501724
[TBL] [Abstract][Full Text] [Related]
17. A prospective evaluation of nesiritide in the treatment of pediatric heart failure.
Jefferies JL; Denfield SW; Price JF; Dreyer WJ; McMahon CJ; Grenier MA; Kim JJ; Dimas VV; Clunie SK; Moffett BS; Chang AC; Wann TI; Smith EO; Towbin JA
Pediatr Cardiol; 2006; 27(4):402-7. PubMed ID: 16830089
[TBL] [Abstract][Full Text] [Related]
18. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
[TBL] [Abstract][Full Text] [Related]
19. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
20. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
